Nathan Ebstein
Impact in
- Infectious Diseases top 2%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
-
- Respiratory Support and Mechanisms
- Pulmonary Hypertension Research and Treatments
Papers in
-
- COVID-19 Clinical Research Studies 9
- SARS-CoV-2 and COVID-19 Research 2
-
- Respiratory Support and Mechanisms 7
- Pulmonary Hypertension Research and Treatments 5
- Co-authors
- Vincent Lévy (1 shared paper)Yacine Tandjaoui-Lambiotte (3 shared papers)Yves Cohen (4 shared papers)Marouane Boubaya (3 shared papers)Philippe Karoubi (2 shared papers)Jean‐Ralph Zahar (2 shared papers)Guillaume Van Der Meersch (2 shared papers)Mohamed Ghalayini (1 shared paper)
- Journals
- Annals of Intensive Care (6 papers)Critical Care (4 papers)European Respiratory Journal (2 papers)EClinicalMedicine (2 papers)JAMA Internal Medicine (2 papers)
- Partner nations
- FranceUnited StatesBelgium
In The Last Decade
Nathan Ebstein
25 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 74
- Infectious Diseases 885
- Pulmonary and Respiratory Medicine 303
- Critical Care and Intensive Care Medicine 30
- Hepatology 44
- Immunology 50
Countries citing papers authored by Nathan Ebstein
This map shows the geographic impact of Nathan Ebstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nathan Ebstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nathan Ebstein more than expected).
Fields of papers citing papers by Nathan Ebstein
This network shows the impact of papers produced by Nathan Ebstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nathan Ebstein. The network helps show where Nathan Ebstein may publish in the future.
Co-authors
The 25 scholars most cited alongside Nathan Ebstein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 599 | |
| 2 | 2021 | 232 | |
| 3 | 2020 | 108 | |
| 4 | 2022 | 99 | |
| 5 | 2023 | 63 | |
| 6 | 2021 | 60 | |
| 7 | 2021 | 38 | |
| 8 | 2020 | 37 | |
| 9 | 2021 | 29 | |
| 10 | 2022 | 22 | |
| 11 | 2022 | 17 | |
| 12 | 2022 | 15 | |
| 13 | 2023 | 13 | |
| 14 | 2021 | 12 | |
| 15 | 2023 | 11 | |
| 16 | 2021 | 10 | |
| 17 | 2023 | 10 | |
| 18 | 2023 | 5 | |
| 19 | 2024 | 4 | |
| 20 | 2024 | 4 |
About Nathan Ebstein
Nathan Ebstein is a scholar working on Infectious Diseases, Pulmonary and Respiratory Medicine, Critical Care and Intensive Care Medicine, Nephrology and Internal Medicine, having authored 27 papers that have together received 1.4k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (9 papers), Respiratory Support and Mechanisms (7 papers), Pulmonary Hypertension Research and Treatments (5 papers), Acute Kidney Injury Research (2 papers), Genetic Associations and Epidemiology (2 papers), Nosocomial Infections in ICU (2 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and Sepsis Diagnosis and Treatment (1 paper). The work is most often cited by research in Infectious Diseases (885 citations), Pulmonary and Respiratory Medicine (303 citations), Critical Care and Intensive Care Medicine (30 citations), Hepatology (44 citations) and Immunology (50 citations). Nathan Ebstein has collaborated with scholars based in France, United States and Belgium. Frequent co-authors include Vincent Lévy, Yacine Tandjaoui-Lambiotte, Yves Cohen, Marouane Boubaya, Philippe Karoubi, Jean‐Ralph Zahar, Guillaume Van Der Meersch, Mohamed Ghalayini, Olivier Martin and Johanna Oziel. Their work appears in journals such as Annals of Intensive Care, Critical Care, European Respiratory Journal, EClinicalMedicine and JAMA Internal Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.